search icon
  • Print
  • ShareThis
  • Text Size
  • The Executive Committee

    BakkenJohan S. Bakken, MD, PhD, FIDSA, President

    Johan Bakken, MD, PhD, FIDSA, is a consultant in infectious diseases at St. Luke’s Hospital and a clinical associate professor at the University of Minnesota Medical School Duluth.
    Dr. Bakken served as chair of the IDSA State and Regional Societies (SRS) Board. During his involvement with the SRS, he demonstrated the value of the ID clinician and advocated for better compensation for the varied services they provide. He has pioneered outpatient parenteral antimicrobial therapy, fecal biotherapy for C. diff, and evidence-based treatment of Lyme disease, contributing to related IDSA guidelines. Currently, he serves on the IDSA Diagnostics Task Force, which is examining the research, development, approval, manufacture, regulation and uptake of infectious diseases diagnostics.
    Dr. Bakken graduated from the University of Washington (UW) School of Medicine in 1972.  He completed an internship in internal medicine at the University of California Los Angeles and subsequent residencies in internal medicine at UW and the Lillehammer Regional Hospital in Norway.  Dr. Bakken did his fellowship in ID at the University of Oslo, Norway, and completed a two-year postdoctoral fellowship in microbiology at Creighton University, Omaha, Nebraska in 1987. 

    William_PowderlyWilliam G. Powderly, MD, FIDSA, President-Elect

    William G. Powderly, MD, FIDSA, is the J. William Campbell Professor of Medicine and co-director of the Division of Infectious Diseases at Washington University School of Medicine in St. Louis. He is director of the Institute for Public Health at Washington University and is an attending physician at Barnes-Jewish Hospital.
    Dr. Powderly’s current research interests include long-term complications of HIV and antiretroviral therapy; fungal infections, especially cryptococcosis, and the translation of clinical advances to public health and public policy.
    He was the inaugural chair of the HIV Medicine Association (HIVMA) of IDSA and was a founding member of the St. Louis Infectious Diseases Society.
    Dr. Powderly graduated from the School of Medicine at University College, Dublin, Ireland in 1979. He did his internship and residency at St. Vincent's Hospital and Mater Misericordiae Hospital in Dublin (1979-1983), and completed his infectious diseases fellowship at the Washington University School of Medicine in 1986.
    He is a Fellow of the Royal College of Physicians of Ireland and the American Association for the Advancement of Science, and is a member of the AIDS Research Advisory Committee, National Institute of Allergy and Infectious Diseases.

    AuwaeterPaul G. Auwaerter, MD, FIDSA, Vice President

    Paul G. Auwaerter, MD, FIDSA, is clinical director in the Division of Infectious Diseases and the Sherrilyn and Ken Fisher Professor of Medicine at Johns Hopkins University School of Medicine.

    Among his contributions to IDSA, he has served on the Annual Meeting Program Committee, the Education Committee, and the Board of Directors, and has supported the Society’s efforts to provide accurate information about Lyme disease to clinicians and the public. Managing editor of the Johns Hopkins Antibiotic Guide, Dr. Auwaerter has also served on the Food and Drug Administration’s Anti-Infective Drugs Advisory Committee and the Board of Scientific Counselors of the National Institute of Allergy and Infectious Diseases. His research interests include Lyme disease, tick-borne diseases, and electronic clinical decision support.

    Dr. Auwaerter graduated from the Columbia University College of Physicians and Surgeons and completed his internship and residency at Johns Hopkins Hospital and his infectious diseases fellowship at Johns Hopkins University School of Medicine. He also earned a master of business administration degree from the Johns Hopkins University School of Professional Studies in Business and Education.

    Penelope DennehyPenelope H. Dennehy, MD, FIDSA, Secretary

    Penelope H. Dennehy, MD, FIDSA, is professor and vice chair for academic affairs in the Department of Pediatrics at Alpert Medical School of Brown University. She is also director of the Division of Pediatric Infectious Diseases at Hasbro Children’s Hospital and program director of the combined Medicine and Pediatric Infectious Diseases Fellowships at Rhode Island Hospital. Her research interests include viral gastroenteritis and viral respiratory diseas¬es in children; clinical trials of vaccines against rotavirus, influenza, and varicella; epidemiology and prevention of rotavirus infections; clinical diagnostic testing for rotavirus; and the epidemiology and etiology of viral gastroenteritis in hospitalized children.
    A past president of the Pediatric Infectious Diseases Society (PIDS), Dr. Dennehy has served as a chair of the IDWeek Program Committee, as the PIDS liaison to the IDSA Board of Directors, and as the IDSA liaison for the Meningococcal Stakeholders Group at the Centers for Disease Control and Prevention. She received the PIDS Distinguished Service Award in 2012.
    Dr. Dennehy graduated from Radcliffe College; earned her medical degree at Tufts University School of Medicine; was an intern and resident in pediatrics at Rhode Island Hospital; and completed her fellowship in infectious diseases at a combined program of Boston Children’s Hospital, Dana Farber Cancer Center and Beth Israel Hospital.

    HelenHelen W. Boucher, MD, FIDSA, Treasurer

    Helen W. Boucher, MD, FIDSA, is associate professor of medicine at Tufts University School of Medicine. She is the director of the Infectious Diseases Fellowship Program at Tufts Medical Center, where she also serves as director of the Ventricular Assist Device and Heart Transplant Infectious Diseases Program in the Division of Geographic Medicine and Infectious Diseases. Dr. Boucher’s clinical interests include infections in immunocompromised patients with an emphasis on transplant-related bacterial and fungal infections and HIV virus as well as S. aureus infections. Her research interests include antimicrobial drug development, S. aureus infection, fungal infections, infections in immunosuppressed patients, and infections related to cardiac assist devices.

    A recipient of the Society Citation in 2015 for her many contributions to IDSA’s efforts to promote the development of new antimicrobial agents, Dr. Boucher has served on several IDSA committees and task forces, including the Antimicrobial Availability Task Force/Antimicrobial Resistance Committee, the Research Committee, the Task Force on ID Recruitment, and the Board of Directors. In 2015, she was appointed to the Presidential Advisory Council on Combating Antibiotic-resistant Bacteria. She is also a member of the American Board of Internal Medicine’s Test Committee and Subspecialty Board on Infectious Diseases.

    A graduate of the University of Texas Medical School, Dr. Boucher completed her internship, residency, and chief residency at New England Deaconess Hospital and her clinical and research fellowships in infectious diseases at Beth Israel Deaconess Medical Center.  

    Calderwood Stephen B. Calderwood, MD, FIDSA, Immediate Past President

    Stephen B. Calderwood, MD, FIDSA, is the Morton N. Swartz, MD Academy Professor of Medicine (Microbiology and Immunobiology) at Harvard Medical School, chief of the Division of Infectious Diseases, vice chair, Department of Medicine, and director of Undergraduate Medical Education at Massachusetts General Hospital.
    He has played an active role in IDSA, having served on the Board of Directors, Society Awards Committee, Training Program Directors Committee, and Education Committee. He is also currently the co-editor-in-chief for the infectious diseases sections of UpToDate.
    Dr. Calderwood is a fellow of the American Academy of Microbiology, American College of Physicians, and the American Association for Advancement of Science, and a member of the Association of American Physicians. He is a past president of the Massachusetts Infectious Diseases Society. Dr. Calderwood graduated from Harvard Medical School, and completed his internship, residency, and clinical and research fellowship in infectious diseases at Massachusetts General Hospital.

    The Board of Directors, 2014-2015

    Johan S. Bakken, MD, PhD, FIDSA, President
    St. Luke’s ID Associates
    Duluth, Minnesota 

    William G. Powderly, MD, FIDSA, President-Elect
    Washington University School of Medicine
    St. Louis, Missouri

    Paul G. Auwaerter, MD, MBA, FIDSA

    Johns Hopkins University School of Medicine
    Baltimore, Maryland

    Penelope H. Dennehy, MD, FIDSA, Secretary
    Hasbro Children’s Hospital/Brown University
    Providence, Rhode Island

    Helen W. Boucher, MD, FIDSA, Treasurer
    Tufts Medical Center
    Boston, Massachusetts

    Stephen B. Calderwood, MD, FIDSA, Immediate Past President
    Massachusetts General Hospital
    Boston, Massachusetts

    Judith A. Aberg, MD, FIDSA, HIVMA Representative
    Icahn School of Medicine at Mount Sinai
    New York, New York

    Barbara D. Alexander, MD, MHS, FIDSA
    Duke University Medical Center
    Durham, NC

    R. Michael Buckley, MD, FIDSA
    University of Pennsylvania Health System
    Philadelphia, Pennsylvania

    Deborah Cotton, MD, MPH, FIDSA
    Boston University School of Medicine
    Boston, Massachusetts

    Janet A. Englund, MD, FIDSA
    Seattle Children's Hospital
    Seattle, Washington

    Thomas Fekete, MD, FIDSA
    Temple University Medical School
    Philadelphia, Pennsylvania

    Lawrence P. Martinelli, MD, FIDSA
    Covenant Health
    Lubbock, Texas

    Louis B. Rice, MD
    Warren Alpert Medical School of Brown University
    Providence, Rhode Island

    Steven K. Schmitt, MD, FIDSA
    Cleveland Clinic
    Cleveland, Ohio

    Mark A. Leasure, Chief Executive Officer
    Arlington, Virginia


Average 0 out of 5

| HIVMA | Contact Us

© Copyright IDSA 2015 Infectious Diseases Society of America

Full Site Mobile Site